Investors Research Corp’s Prestige Consumer Healthcare PBH Stock Holding History

Investors Research Corp’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-700	Closed	-$39K	–	1028
2021 Q3	$39K	Hold	700	–	–	0.01%	562
2021 Q2	$36K	Hold	700	–	–	0.01%	574
2021 Q1	$31K	Hold	700	–	–	0.01%	605
2020 Q4	$24K	Hold	700	–	–	0.01%	693
2020 Q3	$25K	Hold	700	–	–	0.01%	635
2020 Q2	$26K	Hold	700	–	–	0.01%	617
2020 Q1	$26K	Hold	700	–	–	0.02%	561
2019 Q4	$28K	Hold	700	–	–	0.01%	628
2019 Q3	$24K	Hold	700	–	–	0.01%	657
2019 Q2	$22K	Hold	700	–	–	0.01%	676
2019 Q1	$21K	Buy	+700	New	+$20.1K	0.01%	667

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Investors Research Corp's PBH Position: Q4 2021 in Review

Investors Research Corp sold out of Prestige Consumer Healthcare (PBH) in Q4 2021, closing a stake of 700 shares — an estimated $39K sold.

Investors Research Corp first reported a position in PBH in Q1 2019 and held it in 11 quarters. The position peaked at $39K in Q3 2021. 272 funds tracked by Wall St. Rank hold PBH as of Q4 2021.

Investors Research Corp reported no remaining Prestige Consumer Healthcare position as of Q4 2021 after selling out during the quarter.
Investors Research Corp sold 700 Prestige Consumer Healthcare shares in Q4 2021, an estimated $39K.
Investors Research Corp first reported a position in Prestige Consumer Healthcare in Q1 2019 and held it in 11 quarters.
Investors Research Corp's Prestige Consumer Healthcare position peaked at $39K in Q3 2021.
272 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2021.

Based on Investors Research Corp's 13F filing for Q4 2021, filed 27 Jan 2022.